JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 41 No. 1 5-10
© 2000 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sun, D.
Right arrow Articles by Hu, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sun, D.
Right arrow Articles by Hu, W.

Clinical Application of 201Tl SPECT Imaging of Brain Tumors

Da Sun, Qichang Liu, Weiguo Liu and Weiwei Hu

Nuclear Medicine and Neurosurgery Departments, The Second Hospital of the Medical College, Zhejiang University, Hangzhou, People's Republic of China

Correspondence: For correspondence or reprints contact: Da Sun, MD, Nuclear Medicine Department, The Second Hospital of the Medical College, Zhejiang University, Hangzhou, 310009 People's Republic of China.

ABSTRACT

This study investigated the clinical usefulness of evaluating the histologic grade of brain tumors by 201Tl SPECT brain imaging. Methods: Early and delayed SPECT brain images were obtained about 10 min and 3 h, respectively, after intravenous injection of 111MBq (3 mCi) 201Tl in 9 healthy subjects (control subjects), 3 patients with brain hematomas, and 41 patients with brain tumors. Semiquantitative data were obtained for early and delayed 201Tl uptake indices and 201Tl retained index in all patients and healthy subjects. Results: In 9 healthy subjects, there was little radioactivity in brain substance. In all patients with brain hematomas or tumors, a high tracer uptake was visible in lesions on early images, but the radioactivity in lesions varied with the histologic nature of the lesion on delayed images. The radioactivity decreased remarkably in brain hematomas (average retained index, 0.61 ± 0.04). The radioactivity was stable or decreased slightly in benign or low-grade tumors (average retained index, 0.96 ± 0.24). The radioactivity was increased in high-grade or metastatic tumors (average retained index, 1.26 ± 028). Conclusion: This study indicates that 201Tl brain SPECT early and delayed imaging is very useful in brain tumor localization, in distinguishing low-grade from high-grade brain tumors, in predicting histologic grades of brain tumors, and in detecting residual or recurrence of brain tumors postoperatively. 201Tl brain SPECT may also offer the most accurate assessment of response to therapy.

Key Words: 201Tl SPECT • brain tumor • 201Tl retained index




This article has been cited by other articles:


Home page
RadiologyHome page
D. A. Hammoud, J. M. Hoffman, and M. G. Pomper
Molecular Neuroimaging: From Conventional to Emerging Techniques
Radiology, October 1, 2007; 245(1): 21 - 42.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
H. Zhuang, M. Pourdehnad, E. S. Lambright, A. J. Yamamoto, M. Lanuti, P. Li, P. D. Mozley, M. D. Rossman, S. M. Albelda, and A. Alavi
Dual Time Point 18F-FDG PET Imaging for Differentiating Malignant from Inflammatory Processes
J. Nucl. Med., September 1, 2001; 42(9): 1412 - 1417.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2000 by the Society of Nuclear Medicine.